Armstrong Advisory Group, Inc Tiziana Life Sciences LTD Transaction History
Armstrong Advisory Group, Inc
- $1.25 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
32Shares Held
993KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$351,3820.0% of portfolio
-
Morgan Stanley New York, NY111KShares$158,4880.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$150,6710.0% of portfolio
-
Zhang Financial LLC93.2KShares$133,2570.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$113,4910.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $146M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...